Medications for Lymphedema

10 results

Edecrin (ethacrynic acid)

(ethacrynic acid)
Bausch Health US, LLC
Usage: EDECRIN is indicated for treating edema related to congestive heart failure, cirrhosis, renal disease, and nephrotic syndrome. It also manages ascites, idiopathic edema, and lymphedema, particularly in hospitalized pediatric patients. Intravenous use is designated for rapid diuresis in acute situations or when oral administration is not an option.
Bryant Ranch Prepack
Usage: Ethacrynic Acid Tablets are indicated for treating edema when stronger diuretics are needed. They are used for edema related to congestive heart failure, liver cirrhosis, renal disease, as well as for managing ascites, idiopathic edema, lymphedema, and in hospitalized pediatric patients with congenital heart disease or nephrotic syndrome.
ScieGen Pharmaceuticals Inc
Usage: Ethacrynic Acid Tablets are indicated for treating edema when stronger diuretics are needed, including conditions like congestive heart failure, liver cirrhosis, renal disease, and short-term management of ascites, idiopathic edema, lymphedema, and in pediatric patients with congenital heart disease or nephrotic syndrome.
Amneal Pharmaceuticals NY LLC
Usage: Ethacrynic acid tablets are indicated for edema treatment requiring stronger diuretics, including conditions like congestive heart failure, cirrhosis, renal disease, ascites, and more. Intravenous formulation is used for rapid diuresis or when oral administration is not feasible, such as in acute pulmonary edema.
Oceanside Pharmaceuticals
Usage: Ethacrynic acid is indicated for managing edema linked to congestive heart failure, liver cirrhosis, renal disease, malignancy-related ascites, idiopathic edema, lymphedema, and congenital heart disease in hospitalized pediatric patients. It can be administered intravenously for rapid diuresis in acute situations or when oral administration is not feasible.
Meitheal Pharmaceuticals Inc.
Usage: Isosulfan Blue Injection 1% is used for lymphatic vessel delineation to assist in lymphography for conditions such as primary and secondary lymphedema, chyluria, chylous ascites, chylothorax, and lymph node involvement or response to cancer therapy.
AnazaoHealth Corporation
Usage: Isosulfan Blue 1% Injection is used to visualize lymphatic vessels following subcutaneous administration. It serves as an adjunct to lymphography for conditions like lymphedema, chyluria, chylous ascites, chylothorax, and lymph node involvement in neoplasms, facilitating the assessment of the lymphatic system.
Somerset Therapeutics, LLC
Usage: Isosulfan blue injection 1% is indicated for lymphatic vessel delineation in various conditions, including primary and secondary lymphedema, chyluria, chylous ascites, chylothorax, and assessment of lymph node involvement by neoplasms. It serves as an adjunct to lymphography in these clinical scenarios.
Mylan Institutional LLC
Usage: Isosulfan blue injection 1% is used for delineating lymphatic vessels. It serves as an adjunct in lymphography for conditions such as primary and secondary lymphedema, chyluria, chylous ascites, chylothorax, and assessing lymph node involvement in neoplasms or response to therapies.
UNITED STATES SURGICAL CORPORATION
Usage: Lymphazuirn™ 1% (isosulfan blue) is indicated for lymphatic vessel delineation to assist in lymphography. It is used in cases of primary and secondary lymphedema, chyluria, chylous ascites, chylothorax, lymph node involvement in neoplasms, and evaluating lymph node response to therapies.